基于结构-行为-绩效分析范式的药品流通领域供给侧结构性改革策略分析
x
请在关注微信后,向客服人员索取文件
篇名: | 基于结构-行为-绩效分析范式的药品流通领域供给侧结构性改革策略分析 |
TITLE: | |
摘要: | 目的:为我国药品流通行业开展供给侧结构性改革提供产业组织研究基础和发展建议。方法:运用哈佛学派的结构-行为-绩效(SCP)分析范式对2010年以来我国药品流通行业的市场结构、企业行为、经营绩效进行深入研究。结果:自2010年以来,我国药品流通行业呈规模增速下降、市场集中度降低、行业进入壁垒提高、国有资本主导等态势。尽管企业兼并重组和上市融资规模扩大,管理信息化、第三方物流、“互联网+”和药店联盟等经营模式蓬勃发展,但行业经营绩效差,国有企业整体表现不佳。结论:应针对性地加快推进药品流通行业的供给侧结构性改革,鼓励企业融资兼并,破除地方保护主义,发展合作式第三方医药物流和药店联盟,借力互联网推动行业经营模式的转型升级。 |
ABSTRACT: | OBJECTIVE: To provide basic industrial research and development recommendations for the supply-side structural reform in drug distribution in China. METHODS: Structure-conduct-performance (SCP) analysis paradigm from Harvard was used for in-depth study of market structure, business conduct and business performance in China since 2010. RESULTS: Since 2010, drug distribution industry in China had shown the scale of decline in the growth rate, low market concentration, increased barriers to entry, the leading of state-owned capital, etc. Though corporate mergers and acquisitions and public financing expanded the scale, management information, third-party logistics, “Internet+”and pharmacy alliance business model flourished, the industry operating performance was poor, state-owned enterprises showed poor performance. CONCLUSIONS: The transformation and upgrading of the industry business model should be promoted by targetedly accelerating the supply-side structural reforms in the drug distribution industry, encouraging corporate finance mergers, breaking local protectionism, developing cooperative pharmacies and pharmaceutical third-party logistics alliances and leveraging the Internet. |
期刊: | 2017年第28卷第10期 |
作者: | 李璠,余伯阳,曹人元,曹亚茹,洪亮 |
AUTHORS: | LI Fan,YU Boyang,CAO Renyuan,CAO Yaru,HONG Liang |
关键字: | 结构-行为-绩效分析;药品流通;供给侧改革;产业结构升级 |
KEYWORDS: | Structure-conduct-performance analysis; Drug distribution; Supply-side reform; Industry structure upgrading |
阅读数: | 459 次 |
本月下载数: | 8 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!